AbbVie is a global biopharmaceutical company that focuses on developing and marketing advanced therapies for complex and serious diseases. With expertise, dedicated people, and a unique approach to innovation, AbbVie aims to have a remarkable impact on people's lives in various therapeutic areas such as immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology. The company was formed in 2013 after separating from Abbott and currently employs approximately 21,000 people worldwide, marketing medicines in over 170 countries. AbbVie's mission is to address the medical challenges of today and tomorrow, with a particular emphasis on its Allergan Aesthetics portfolio.